Progress in the study of the effects of medical nutrition therapy on adverse pregnancy outcomes in patients with gestational diabetes mellitus and their offspring

Xiaoying Hou

doi:10.54254/2753-8818/15/20240453

Research Article

Open access

Published on 4 December 2023

Download pdf

Hou,X. (2023). Progress in the study of the effects of medical nutrition therapy on adverse pregnancy outcomes in patients with gestational diabetes mellitus and their offspring. Theoretical and Natural Science,15,67-70.

Export citation

Progress in the study of the effects of medical nutrition therapy on adverse pregnancy outcomes in patients with gestational diabetes mellitus and their offspring

Xiaoying Hou *^,1,

¹ Hong Kong Baptist University

* Author to whom correspondence should be addressed.

https://doi.org/10.54254/2753-8818/15/20240453

Abstract

Gestational diabetes mellitus (GDM) belongs to a particular type of diabetes mellitus. Not only are patients with GDM at a more significant risk of converting to diabetes mellitus later in life, but GDM can also have both short-term and long-term effects on the health of the mother and child, such as congenital anomalies, spontaneous abortions, macrosomia, preterm labor, excessive amniotic fluid, and many other adverse outcomes. Medical nutrition therapy (MNT) interventions for patients with GDM can be extremely beneficial to the pregnancy outcomes of GDM patients and their offspring by helping them to act on their individual and clear health goals and adopt healthy behaviors. The article starts from the effect of MNT on the pregnancy outcome of GDM patients and their offspring, reviews the latest research progress on the adverse pregnancy outcome of GDM patients and their offspring, and analyzes the problems and importance of medical nutrition therapy for GDM patients with the aim of better promoting the outcome of GDM patients’ mothers and infants, and reaching the long-term effect of MNT.

Keywords

Medical Nutrition Therapy, Gestational Diabetic Patients, Adverse Pregnancy Outcomes, Offspring Effects

View pdf

References

[1]. Cho N.H.,Shaw J.E., Karuranga S.,et al. (2018) IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice,138: 271-281.

[2]. Kuhl C. (1991) Insulin secretion and insulin resistance in pregnancy and GDM: Implications for diagnosis and management. Diabetes, 2: 18-24.

[3]. Endo S., Maeda K., Suto M., et al. (2006) Differences in insulin sensitivity in pregnant women with overweight and gestational diabetes mellitus. Gynecological Endocrinology, 22 (6), 343-349.

[4]. Sugiyama T., Metoki H., Hamada H., et al. (2014) A retrospective multi-institutional study of treatment for mild gestational diabetes in Japan. Diabetes Research and Clinical Practice, 103(3): 412-418.

[5]. Chu S.Y., Callaghan W.M., Kim S.Y., et al. (2007) Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care, 30: 2070-6.

[6]. Moosazadeh M., Asemi Z., Lankarani K.B.,et al. (2017) Family history of diabetes and the risk of gestational diabetes mellitus in Iran: a systematic review and meta-analysis. Diabetes & Metabolic Syndrome Clinical Research & Reviews, 11(1): 99-104.

[7]. Aldasouqi S.A., Solomon D.J., Bokhari S.A., et al. (2008) Glycohemoglobin A1c: a promising screening tool in gestational diabetes mellitus. International Journal of Diabetes in Developing Countries, 28(4): 121-124.

[8]. Cheng J. (2013) Study on the risk factors of gestational diabetes mellitus and its impact on pregnancy outcome of mother and baby. Journal of Clinical Rational Drug Use, 6(12): 19-19.

[9]. Wei Y., Yang H. (2018) Perspectives on diagnostic strategies for hyperglycemia in pregnancy: dealing with the barriers and challenges in China. Diabetes Research and Clinical Practice, 145: 84‐87.

Cite this article

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Volume title: Proceedings of the 2nd International Conference on Modern Medicine and Global Health

Conference website: https://www.icmmgh.org/

ISBN：978-1-83558-193-3(Print) / 978-1-83558-194-0(Online)

Conference date: 5 January 2024

Editor：Mohammed JK Bashir

Series: Theoretical and Natural Science

Volume number: Vol.15

ISSN：2753-8818(Print) / 2753-8826(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).